The White Matter Speaks: A Survey of Hallucinogens Through the Myelin Mind Lens

Dr Jack Parry 28 April 2026

keywords: hallucinogens psilocybin ketamine ibogaine DMT mescaline myelin oligodendrocyte hallucination chiasm

The Myelin Mind thesis proposes that consciousness arises at the chiasm, the encounter between grey matter arriving through the senses and the accumulated myelinated condition that meets it. Perception is that encounter. The river of neural flow meets its myelinated bed, and consciousness happens there, at the contact point, nowhere else.

A hallucination, on this account, is the chiasm firing without a clear incoming signal. The white matter speaks without being called. The accumulated condition of the self generates experience from its own interior rather than from the world outside. The river runs, but the rain has stopped. The bed is producing its own current.

What follows is a survey of the major classes of hallucinogenic substance through this lens, asking a single question of each: where does it reach the myelination process, and what does that tell us about why it produces the experience it produces?

I do not give medical advice, and nothing here constitutes a recommendation. I hold a PhD, not a medical degree.

The serotonergic class: psilocybin, LSD, DMT, mescaline

The classical hallucinogens share a primary target: the serotonin 5-HT2A receptor. This receptor sits not only on neurons but on oligodendrocyte lineage cells throughout the developing and adult brain. When serotonin levels are artificially elevated, as with SSRI exposure in culture, the effect on OPCs is damaging: aberrant process outgrowth, reduced myelin protein expression, and, at higher concentrations, cell death mediated specifically through the 5-HT2A receptor.

Psilocybin does something more subtle. A 2024 study found that a single dose induces expression of an immediate-early activity marker in oligodendrocytes, confirming direct cellular engagement, not merely an indirect glial bystander effect. The oligodendrocyte is responding to the psilocybin signal as if something important is happening.

The more remarkable finding is from a 2023 paper in Science. Classical psychedelics, including psilocybin and DMT, activate 5-HT2A receptors located inside the cell rather than on the membrane surface. These intracellular receptors appear to be the ones responsible for the neuroplasticity effects. And crucially, serotonin itself does not activate them: its molecular structure prevents it from penetrating the cell membrane. The receptor is there. The body’s own ligand cannot reach it. The hallucinogen can. What it activates is a receptor that the nervous system itself cannot routinely access.

The Myelin Mind reading of this is that the serotonergic hallucinogens activate a signalling pathway within glial and neural cells that sits beneath the ordinary flow of serotonin, a reserve channel, normally closed, opening briefly under the influence of molecules small enough and permeable enough to reach it. What the chiasm ordinarily does with incoming neural flow, the hallucinogen is doing from the inside.

LSD shares this 5-HT2A profile and adds a direct binding affinity for TrkB receptors, the same receptors that BDNF uses to promote neuroplasticity and oligodendrocyte maturation. In this sense LSD is not simply mimicking serotonin. It is reaching multiple myelination-related targets that serotonin itself cannot reach. The accumulated condition of the white matter is being activated directly, without the grey matter calling the signal in.

Mescaline sits within the same serotonergic class. Its phenomenology, less architecturally complex than psilocybin, more sensory and coloured, may reflect a somewhat different receptor profile within the same family. The Myelin Mind would predict that subtleties in OPC receptor subtype expression across brain regions would produce the regional differences in hallucination character across these compounds.

The dissociative class: ketamine, PCP, nitrous oxide

The dissociatives work through a completely different molecular route: they block the NMDA glutamate receptor. NMDA receptors are expressed on oligodendrocyte precursor cells, and they regulate OPC differentiation and the transition to myelination. Block them, and the OPC signalling environment changes. The chiasm, which depends on the precise calibration of grey-white encounter, is disrupted from the white matter side.

Ketamine produces a distinctive experience: not the complex visual architecture of psilocybin but a floating dissociation from the body, a sense that self and world have come apart at their seam. On the Myelin Mind account, this is precisely what NMDA blockade would produce. The grey matter is still arriving. The white matter is no longer receiving it normally. The chiasm does not close. It drifts. The river continues but the bed is elsewhere.

The most striking finding in the ketamine literature for the Myelin Mind thesis is from a 2023 paper in Molecular Psychiatry: ketamine’s long-lasting antidepressant effects, which outlast its presence in the brain by days, appear to depend on its promotion of OPC differentiation into mature myelinating oligodendrocytes. When the relevant myelin protein was blocked, the antidepressant effect disappeared. Ketamine, the dissociative hallucinogen, is doing part of its therapeutic work in white matter. The lasting repair it produces in the depressed brain is, at least partly, a myelination story.

Chronic high-dose ketamine use produces the opposite: measurable white matter microstructural abnormalities in frontal and parietal pathways, with the degree of disruption correlating with the severity of dissociative experience. The same molecule, at the same target, produces remyelination at one dose and demyelination at another. The chiasm is exquisitely sensitive to how the signal arrives.

Nitrous oxide, the oldest of the dissociatives, sits in the same NMDA-blocking class. Its characteristic experience, brief euphoria tipping quickly into dissociation and then silence, maps onto transient NMDA blockade followed by rapid recovery as the gas clears. Its interaction with white matter is indirect, via the NMDA receptor and the B12 inactivation discussed in the Undocumented Side Effects article, rather than a direct OPC effect.

Ibogaine: the molecule that finds the opioid receptors in white matter

Ibogaine occupies its own category. It is not primarily serotonergic, not primarily a dissociative. Its receptor profile is complex: it binds to opioid receptors, NMDA receptors, and serotonin transporters among others. Its phenomenology is correspondingly unlike any other hallucinogen: a long, demanding, often unpleasant journey, reported by many who undergo it as a confrontation with their own life history rather than a perceptual transformation of the present world. The accumulated condition of the self, reviewed from the outside.

The white matter connection is new and striking. A 2024 study confirmed that ibogaine upregulates the two primary markers of myelination, myelin basic protein and CNPase, directly in the internal capsule of rats who had been given repeated morphine. This happened in white matter. The myelination process was being reactivated following the damage that opioid exposure had caused. Ibogaine appears to be partially reversing what the opioid had done to white matter.

The mechanism involves the kappa opioid receptor, which ibogaine targets alongside mu opioid receptors. OPCs express kappa opioid receptors, and those receptors regulate OPC differentiation and remyelination. Ibogaine’s action on that receptor may be part of why it appears to interrupt addiction: the opioid has inscribed a false myelinated condition, the catastrophic remyelination in the wrong direction described in the Pleasure Principle article, and ibogaine is beginning to rewrite the inscription.

The phenomenology, the life review, the confrontation with the accumulated self, may be the first-person experience of white matter reorganising under the influence of a molecule that speaks directly to OPCs.

Cannabinoids

Covered in the companion article Two Cigarettes. The short version: OPCs produce their own endocannabinoids and express CB1 and CB2 receptors, making them full participants in the endocannabinoid system rather than merely passive recipients. Cannabis is speaking into a conversation the white matter is already having with itself.

The pattern

Every major class of hallucinogen touches either OPCs directly or the signalling systems through which axonal activity drives myelination. This is not coincidence, and it is not explained by the wired-mind framework, which would locate all hallucinogenic effects in synaptic transmission and have nothing to say about why the cells that build white matter are listening.

The Myelin Mind reading is that the hallucinogens are, each in their own way, speaking to the accumulated condition. They are activating the white matter from the inside, through receptor systems that are native to the myelination process, and the first-person experience of that activation is hallucination: the chiasm running without its full complement of incoming signal, generating experience from the accumulated condition alone.

This does not mean hallucinations are not real. It means they are real in a specific way: they are the white matter speaking. They are the accumulated condition of the self, built over a lifetime of encounter with the world, briefly becoming its own source.

What you see during a psilocybin journey is what your white matter knows. Not what the world is sending. What you have become.